Jode Goodridge

420 citations
20 papers · 285 · 1 hit paper · h-index 8

Impact in

    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
  • Oncology top 10%
    • CAR-T cell therapy research

Papers in

    • CAR-T cell therapy research 20
    • Immune Cell Function and Interaction 11
    • Immunotherapy and Immune Responses 3
    • T-cell and B-cell Immunology 2

Jode Goodridge

20 papers receiving 278 citations

Jode Goodridge's Hit Papers

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial 2025 · 42 citations
420Years since publication10203040

Peers

Jode Goodridge
Comparison fields: 5 of 24
  • Immunology 187
  • Oncology 240
  • Hematology 28
  • Genetics 42
  • Molecular Biology 83
Replace Greg Bonello with:
Greg Bonello United States
Katherine A. Freitas United States
Lorena Pérez-Amill Spain
Yaara Ohayon United States
Kayla Reid United States
Nathaniel Dasyam New Zealand
Brianna Flynn United States
Yue Tan China
Licui Jiang China
Amod Sarnaik United States
Jode Goodridge relative to Greg Bonello United States Greg Bonello's profile →
Citations per field
00.5×2.7×
Greg Bonello · 1×
Citations per year

Countries citing papers authored by Jode Goodridge

Since Specialization
Citations

This map shows the geographic impact of Jode Goodridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jode Goodridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jode Goodridge more than expected).

Fields of papers citing papers by Jode Goodridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jode Goodridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jode Goodridge. The network helps show where Jode Goodridge may publish in the future.

Co-authors

The 25 scholars most cited alongside Jode Goodridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jode Goodridge Line = papers co-authored together Jode Goodridge links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201966
2
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
Hit paper breakdown →
202542
3 202241
4 202034
5 201926
6 202418
7 202218
8 20219
9 20227
10 20217
11 20225
12 20212
13 20222
14 20222
15 20241
16 20211
17 20191
18 20201
19 20191
20 20221

About Jode Goodridge

Jode Goodridge is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Organic Chemistry, having authored 20 papers that have together received 285 indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (11 papers), RNA Interference and Gene Delivery (4 papers), CRISPR and Genetic Engineering (4 papers), Immunotherapy and Immune Responses (3 papers), Multiple Myeloma Research and Treatments (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (187 citations), Oncology (240 citations), Hematology (28 citations), Genetics (42 citations) and Molecular Biology (83 citations). Jode Goodridge has collaborated with scholars based in United States, Norway and Sweden. Frequent co-authors include Bahram Valamehr, Tom Lee, Ryan Bjordahl, Karl‐Johan Malmberg, Svetlana Gaidarova, Brian Groff, Greg Bonello, Sajid Mahmood, Robert Blum and Lilly Wong. Their work appears in journals such as Blood, Cancer Research, Cell stem cell, The Lancet and Regular and Young Investigator Award Abstracts.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact